Rhabdomyolyse: prise en charge médicale initiale [Rhabdomyolysis: early management]
Details
Request a copy Under indefinite embargo.
UNIL restricted access
State: Public
Version: author
License: Not specified
UNIL restricted access
State: Public
Version: author
License: Not specified
Serval ID
serval:BIB_00478ABB09C3
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Rhabdomyolyse: prise en charge médicale initiale [Rhabdomyolysis: early management]
Journal
Revue medicale suisse
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
25/11/2020
Peer-reviewed
Oui
Volume
16
Number
716
Pages
2272-2278
Language
french
Notes
Publication types: English Abstract ; Journal Article
Publication Status: ppublish
Publication Status: ppublish
Abstract
Rhabdomyolysis is defined by myalgia, potentially painful myoedema and muscular weakness due to death of muscular fiber in the striated muscle. Frequent etiologies include physical effort, intoxication (alcohol, drugs and medication) and physical trauma. Depletion of myocyte' s adenosine triphosate (ATP) leads to an increase in intracellular calcium and myocyte death. Diagnosis relies on creatine kinase (CK) levels. The clinical spectrum of rhabdomyolysis includes an asymptomatic increased amount of CK as well as severe, life threatening complications such as acute renal failure and electrolyte disorders. Treatment is based on prevention and addressing complications.
Pubmed
Create date
26/11/2020 22:04
Last modification date
19/08/2022 5:40